Satabdi Biswas
Overview
Explore the profile of Satabdi Biswas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dey D, Biswas S, Pal S, Nandi S, Khatun N, Jha R, et al.
Front Immunol
. 2024 Oct;
15:1474853.
PMID: 39445017
Introduction: Patients with chronic HBV infection (CHI) exhibit defective anti-viral immune-response whose underlying causes still remain unclear. Monocytes act as immune sentinels for pathogens and can regulate immunity via interaction...
2.
Howlader D, Mandal R, Lu T, Maiti S, Dietz Z, Das S, et al.
Front Immunol
. 2024 May;
15:1372349.
PMID: 38698863
(Pa) is an opportunistic bacterial pathogen responsible for severe hospital acquired infections in immunocompromised and elderly individuals. Emergence of increasingly drug resistant strains and the absence of a broad-spectrum prophylactic...
3.
Bhattacharjee A, Majumder S, Das S, Ghosh S, Biswas S, Majumdar S
Infect Immun
. 2016 Aug;
84(10):2963-73.
PMID: 27481248
Visceral leishmaniasis (VL) is the second-largest parasitic killer disease after malaria. During VL, the protozoan Leishmania donovani induces prostaglandin E2 (PGE2) generation within host macrophages to aid parasite survival. PGE2...
4.
Jawed J, Majumder S, Bandyopadhyay S, Biswas S, Parveen S, Majumdar S
Pathog Dis
. 2016 May;
74(5).
PMID: 27150838
Emergence of drug resistance during visceral leishmaniasis (VL) is a major obstacle imposed during successful therapy. An effective vaccine strategy against this disease is therefore necessary. Our present study exploited...
5.
Chowdhury B, Das S, Majumder S, Halder K, Ghosh S, Biswas S, et al.
Pathog Dis
. 2015 Aug;
73(8):ftv063.
PMID: 26297915
Visceral leishmaniasis (VL), caused by a protozoan parasite Leishmania donovani, is still a threat to mankind due to treatment failure, drug resistance and coinfection with HIV. The limitations of first-line...